Search Results - "Penati, G."

Refine Results
  1. 1

    Alexithymia and obesity. Study of the impaired symbolic function by the Rorschach test by Clerici, M, Albonetti, S, Papa, R, Penati, G, Invernizzi, G

    Published in Psychotherapy and psychosomatics (1992)
    “…Many authors consider alexithymia a predisposing factor to psychosomatic and somatopsychic pathologies. In this study we investigated the presence of…”
    Get more information
    Journal Article
  2. 2

    Beta-endorphin, vasoactive intestinal peptide and cholecystokinin in peripheral blood mononuclear cells from healthy subjects and from drug-free and haloperidol-treated schizophrenic patients by Panza, G, Monzani, E, Sacerdote, P, Penati, G, Panerai, A E

    Published in Acta psychiatrica Scandinavica (01-03-1992)
    “…Beta-endorphin, cholecystokinin and vasoactive intestinal peptide were measured in peripheral blood mononuclear cells of healthy controls, and schizophrenic…”
    Get more information
    Journal Article
  3. 3

    Eating Attitudes Test and culture: a study in northern and southern Italy by Ruggiero, G M, Mantero, M, Asti, M, Agostinelli, M L, Casaccio, F, Garghentini, P G, Gozzini, C, Zita, G, Penati, G

    Published in Eating and weight disorders (01-06-1999)
    “…The EAT (Eating Attitudes Test) has been widely used to compare eating morbidity in cultural groups and variations in it have been taken as indicative of…”
    Get full text
    Journal Article
  4. 4

    Bromocriptine therapy in chronic schizophrenia: effects on symptomatology, sleep patterns, and prolactin response to stimulation by Brambilla, F, Scarone, S, Pugnetti, L, Massironi, R, Penati, G, Nobile, P

    Published in Psychiatry research (01-03-1983)
    “…Ten chronic schizophrenic patients were given bromocriptine in doses increasing from 1.25 to 5 mg over 6 days (the low-dose therapy) and then up to 40 mg over…”
    Get more information
    Journal Article
  5. 5
  6. 6

    Psychiatric symptoms do not correlate with cognitive decline, motor symptoms, or CAG repeat length in Huntington's disease by Zappacosta, B, Monza, D, Meoni, C, Austoni, L, Soliveri, P, Gellera, C, Alberti, R, Mantero, M, Penati, G, Caraceni, T, Girotti, F

    Published in Archives of neurology (Chicago) (01-06-1996)
    “…To investigate the hypothesis that psychiatric disturbances in Huntington's disease are related to degree of cognitive or motor compromise and to determine…”
    Get more information
    Journal Article
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20